CanPoland Clinics with the first location

CanPoland Clinics with the first location

CanPoland Clinics with the first location 150 150 CanPoland SA
www.canpoland.com

A subsidiary of CanPoland SA – CanPoland Clinics – is opening the first clinic. The medical center will be opened in Warsaw at al. KEN 103, next to the Ursynów metro station in Q3 2021. The clinic will be ready in Q3 2021. There will be four offices and a space for patients on the area of ​​152 sqm.  The architect Joanna Basińska is responsible for the interior design.

The clinic will see doctors of four specialties: neurologist, oncologist, urologist and anesthesiologist/pain specialist. CanPoland is in the process of recruiting the team of the clinic. It is very likely that the stuff will be joined by a doctor who is one of the top Polish specialists in treatments including cannabinoid therapy. The facility will also provide telemedicine services.

“We are consequently implementing the next strategic tasks that are leading us to the main market of the WSE. The next clinics of the chain will be opened in major Polish cities. Advanced negotiations are taking place in the south of the country,” adds Zbigniew Pisarski, co-founder and chairman of the supervisory board of CanPoland.

About CanPoland SA

CanPoland SA is the first Polish-owned pharmaceutical company to trade internationally in medical marijuana. It’s also the first in Poland to build a production plant that is allowed to manufacture medical marijuana. The company is also active on the pharmaceutical repackaging services market and acts as the wholesaler of pharmaceuticals. In 2020, the company managed to acquire TT Pharma Sp. z o.o. (owned by the pharmaceutical giant Pelion SA) as its investor, now owning a 30 percent share in CanPoland SA. In order to implement the strategy of a vertical business organization (from cultivation to sale), together with the Canadian investor ICC (also active in the cannabis industry), CanPoland set up the The Health Company Poland. Its main area of activity is the production and distribution of raw materials, semi-finished products and a wide variety of final products from the “life science” range, based on active hemp substances. The company’s offer is aimed at both the B2B market and the consumer market. The Health Company Poland works along the entire supply chain, from research and development plants and laboratories, through cultivation and modern technological and processing solutions, to direct sale of the highest quality cannabis products for business and the end consumer. The Health Company’s offer is available on the https://hempcloud.pl platform.

Ta strona używa plików cookie w celu usprawnienia i ułatwienia dostępu do serwisu oraz prowadzenia danych statystycznych. Dalsze korzystanie z tej witryny oznacza akceptację tego stanu rzeczy.
Polityka Cookies